Glaucoma
1,009
94
120
582
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
173 trials with published results (17%)
Research Maturity
582 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
56 terminated out of 1009 trials
91.2%
+4.7% vs benchmark
22%
217 trials in Phase 3/4
30%
173 of 582 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 582 completed trials
Clinical Trials (1009)
Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)
Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension
Ocular Blood Flow Assessment in Glaucoma
A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma
Village-Integrated Eye Worker Trial II
Tolerability of an Anesthesia-free Tonometer Tip
Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI
Comparison of Safety and Efficacy of Hydrus and iStent Combined With Phacoemulsyfication in Open Angle Glaucoma Patients Long-Term Follow-Up
Efficacy and Safety of XEN63 Gel Implant
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
SD-OCT Multimodal Analysis in GLaucoma
Rocklatan vs Latanoprost Post-DSLT
Intraocular Pressure During Static Apnea
Morphometric Markers of the Effectiveness of Micropulse Cyclophotocoagulation
Tear Interleukin Biomarkers After Glaucoma Treatment
Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test
Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study
Choroidal and Retinal Features in PACD and POAG on OCT and OCTA
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension